Life Sciences Oxford BioDynamics Announces US Launch Of Its Checkpoint Inhibitor Response Test (EpiSwitch CiRT)… AIT News Desk Feb 28, 2022 First-of-its-kind precision medicine test to predict a cancer patient’s response to an Immune Checkpoint Inhibitor (ICI) Provides…